Brush cytology vs. endoscopic biopsy for the surveillance of Barretts esophagus

Endoscopy

Volumn 42, Issue 10, 2010, Pages 800-805

  Kumaravel, A ^a   Lopez, R ^a   Brainard, J ^a   Falk, G W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; COHORT ANALYSIS; CYTOLOGY; DIAGNOSTIC VALUE; DYSPLASIA; ENDOSCOPIC BIOPSY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; BIOPSY; COHORT STUDIES; CYTODIAGNOSIS; DISEASE PROGRESSION; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 77957300061     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0030-1255710     Document Type: Article

References (43)

1. Hirota W K., Zuckerman M J., Adler D G. et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006 63 570-580
2. Sharma P, McQuaid K, Dent J et al. A critical review of the diagnosis and management of Barretts esophagus: the AGA Chicago Workshop. Gastroenterology 2004 127 310-330
3. Wang K K., Sampliner R E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barretts esophagus. Am J Gastroenterol 2008 103 788-797
4. Falk G W., Ours T M., Richter J E. Practice patterns for surveillance of Barretts esophagus in the united states. Gastrointest Endosc 2000 52 197-203
5. Alexander J A., Jones S M., Smith C J. et al. Usefulness of cytopathology and histology in the evaluation of Barretts esophagus in a community hospital. Gastrointest Endosc 1997 46 318-320
6. Geisinger K R., Teot L A., Richter J E. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barretts esophagus. Cancer 1992 69 8-16
7. Hardwick R H., Morgan R J., Warren B F. et al. Brush cytology in the diagnosis of neoplasia in Barretts esophagus. Dis Esophagus 1997 10 233-237
8. Robey S S., Hamilton S R., Gupta P K., Erozan Y S. Diagnostic value of cytopathology in Barrett esophagus and associated carcinoma. Am J Clin Pathol 1988 89 493-498
9. Saad R S., Mahood L K., Clary K M. et al. Role of cytology in the diagnosis of Barretts esophagus and associated neoplasia. Diagn Cytopathol 2003 29 130-135
10. Wang H H., Doria M I. Jr., Purohit-Buch S et al. Barretts esophagus. The cytology of dysplasia in comparison to benign and malignant lesions. Acta Cytol 1992 36 60-64
11. Wang H H., Jonasson J G., Ducatman B S. Brushing cytology of the upper gastrointestinal tract. Obsolete or not? Acta Cytol 1991 35 195-198
12. Wang H H., Sovie S, Zeroogian J M. et al. Value of cytology in detecting intestinal metaplasia and associated dysplasia at the gastroesophageal junction. Hum Pathol 1997 28 465-471
13. Fritcher E G., Brankley S M., Kipp B R. et al. A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barretts esophagus. Hum Pathol 2008 39 1128-1135
14. Falk G W. Cytology in Barretts esophagus. Gastrointest Endosc Clin N Am 2003 13 335-348
15. Falk G W., Chittajallu R, Goldblum J R. et al. Surveillance of patients with Barretts esophagus for dysplasia and cancer with balloon cytology. Gastroenterology 1997 112 1787-1797
16. Kariv R, Plesec T P., Goldblum J R. et al. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol 2009 7 653-658
17. Montgomery E, Bronner M P., Goldblum J R. et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001 32 368-378
18. Petras R E., Sivak M V. Jr., Rice T W. Barretts esophagus. A review of the pathologists role in diagnosis and management. Pathol Annu 1991 26 Pt 2 1-32
19. Reid B J., Weinstein W M., Lewin K J. et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barretts esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988 94 81-90
20. Liu H, Wu T. Estimating the area under a receiver operating characteristic curve for repeated measures design. J Stat Softw 2003 8 1-18
21. Mandal A, Playford R J., Wicks A C. Current practice in surveillance strategy for patients with Barretts oesophagus in the UK. Aliment Pharmacol Ther 2003 17 1319-1324
22. Goldblum J R., Lauwers G Y. Dysplasia arising in barretts esophagus: diagnostic pitfalls and natural history. Semin Diagn Pathol 2002 19 12-19
23. Kerkhof M, van Dekken H, Steyerberg E W. et al. Grading of dysplasia in Barretts oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 2007 50 920-927
24. Reid B J., Haggitt R C., Rubin C E. et al. Observer variation in the diagnosis of dysplasia in Barretts esophagus. Hum Pathol 1988 19 166-178
25. Dulai G S., Shekelle P G., Jensen D M. et al. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barretts cohort. Am J Gastroenterol 2005 100 775-783
26. Lim C H., Treanor D, Dixon M F., Axon A T. Low-grade dysplasia in Barretts esophagus has a high risk of progression. Endoscopy 2007 39 581-587
27. Skacel M, Petras R E., Gramlich T L. et al. The diagnosis of low-grade dysplasia in Barretts esophagus and its implications for disease progression. Am J Gastroenterol 2000 95 3383-3387
28. Skacel M, Petras R E., Rybicki L A. et al. p53 expression in low grade dysplasia in Barretts esophagus: correlation with interobserver agreement and disease progression. Am J Gastroenterol 2002 97 2508-2513
29. Wani S, Puli S R., Shaheen N J. et al. Esophageal adenocarcinoma in Barretts esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol 2009 104 502-513
30. Rossi E, Villanacci V, Bassotti G et al. Her-2/neu in barrett esophagus: a comparative study between histology, immunohistochemistry, and fluorescence in situ hybridization. Diagn Mol Pathol 2006 15 125-130
31. Cestari R, Villanacci V, Rossi E et al. Fluorescence in situ hybridization to evaluate dysplasia in Barretts esophagus: a pilot study. Cancer Lett 2007 251 278-287
32. Brien T P., Odze R D., Sheehan C E. et al. HER-2/neu gene amplification by FISH predicts poor survival in Barretts esophagus-associated adenocarcinoma. Hum Pathol 2000 31 35-39
33. Fahmy M, Skacel M, Gramlich T L. et al. Chromosomal gains and genomic loss of p53 and p16 genes in Barretts esophagus detected by fluorescence in situ hybridization of cytology specimens. Mod Pathol 2004 17 588-596
34. Falk G W., Skacel M, Gramlich T L. et al. Fluorescence in situ hybridization of cytologic specimens from Barretts esophagus: a pilot feasibility study. Gastrointest Endosc 2004 60 280-284
35. Krishnadath K K., Tilanus H W., Alers J C. et al. Detection of genetic changes in Barretts adenocarcinoma and Barretts esophagus by DNA in situ hybridization and immunohistochemistry. Cytometry 1994 15 176-184
36. Rygiel A M., van Baal J W., Milano F et al. Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population. Cancer 2007 109 1980-1988
37. Brankley S M., Wang K K., Harwood A R. et al. The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barretts esophagus. J Mol Diagn 2006 8 260-267
38. Prasad G A., Wang K K., Halling K C. et al. Utility of biomarkers in prediction of response to ablative therapy in Barretts esophagus. Gastroenterology 2008 135 370-379
39. Borovicka J, Schonegg R, Hell M et al. Is there an advantage to be gained from adding digital image cytometry of brush cytology to a standard biopsy protocol in patients with Barretts esophagus? Endoscopy 2009 41 409-414
40. Huang Q, Yu C, Zhang X, Goyal R K. Comparison of DNA histograms by standard flow cytometry and image cytometry on sections in Barretts adenocarcinoma. BMC Clin Pathol 2008 8 5
41. Lin X, Finkelstein S D., Zhu B et al. Loss of heterozygosities in Barrett esophagus, dysplasia, and adenocarcinoma detected by esophageal brushing cytology and gastroesophageal biopsy. Cancer Cytopathol 2009 117 57-66
42. Rygiel A M., Milano F, Ten Kate F J. et al. Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barretts esophagus brush cytology specimens. Genes Chromosomes Cancer 2008 47 396-404
43. Tomizawa Y, Wang K K. Changes in screening, prognosis and therapy for esophageal adenocarcinoma in Barretts esophagus. Curr Opin Gastroenterol 2009 25 358-365